Loading...
Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma
Gold glyconanoparticles loaded with the listeriolysin O peptide 91–99 (GNP-LLO(91-99)), a bacterial peptide with anti-metastatic properties, are vaccine delivery platforms facilitating immune cell targeting and increasing antigen loading. Here, we present proof of concept analyses for the considerat...
Na minha lista:
| Udgivet i: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6343812/ https://ncbi.nlm.nih.gov/pubmed/30713801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1541534 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|